Divi's Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Divi's Laboratories Ltd. on BSE

Load latest

Divi's Laboratories Ltd.

06 Mar 2012

6527.00

-0.34%

Board Meeting

Outcome of Compensation Committee Meeting

BSE India

Divis Laboratories Ltd has informed BSE that Compensation Committee of Board of Directors in its meeting held on March 05, 2012 made the allotment of 31180 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the Company will get increased to 132734290 equity shares from 132703110 equity shares of face value Rs. 2/- each.

Divi's Laboratories Ltd.

28 Jan 2012

6527.00

-0.34%

Company Update

Resignation of Director

BSE India

Divis Laboratories Ltd has informed BSE that Dr. P. Gundu Rao, Non-Executive Director of the Company has resigned from the Board as he relocated to the USA to spend time with his family.The Board has accepted his resignation and appreciated his contribution to the Company.

Divi's Laboratories Ltd.

28 Jan 2012

6527.00

-0.34%

Result

Limited Review for Dec 31, 2011

BSE India

Divis Laboratories Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended December 31, 2011.

pdf

Divi's Laboratories Ltd.

28 Jan 2012

6527.00

-0.34%

Result

Announces Q3 Results & Results Press Release for the quarter ended on Dec 31, 2011

BSE India

Divis Laboratories Ltd has announced the following results for the quarter ended December 31, 2011:The Unaudited results for the Quarter ended December 31, 2011The Company has posted a net profit of Rs. 1225.50 million for the quarter ended December 31, 2011 as compared to Rs. 1015.70 million for the quarter ended December 31, 2010. Total Income has increased from Rs. 3220.60 million for the quarter ended December 31, 2010 to Rs....

pdf

Divi's Laboratories Ltd.

18 Jan 2012, 03:46PM

6527.00

-0.34%

Board Meeting

Q3 results on Jan 28, 2012

BSE India

Divis Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 28, 2012, inter alia, to consider and take on record the un-audited financial results for the third quarter ended December 31, 2011 (Q3).

Divi's Laboratories Ltd.

01 Nov 2011

6527.00

-0.34%

Company Update

Results Press Release

BSE India

Divis Laboratories Ltd has informed BSE regarding a Press Release dated November 01, 2011 titled "Divi's Labs earns an Income of Rs. 366 crores in Q2 of FY11-12"

pdf

Divi's Laboratories Ltd.

01 Nov 2011

6527.00

-0.34%

Board Meeting

Outcome of Compensation Committee Meeting

BSE India

Divis Laboratories Ltd has informed BSE that Compensation Committee of Board of Directors in its meeting held on November 01, 2011 made the allotment of 26560 equity shares of Rs. 2/- each to the employees under ESOP2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the Company will get increased to 132703110 equity shares from 132676550 equity shares of face value Rs. 2/- each.

Divi's Laboratories Ltd.

01 Nov 2011

6527.00

-0.34%

Result

Announces Q2 results

BSE India

Divis Laboratories Ltd has announced the following results for the quarter ended September 30, 2011:The Unaudited results for the Quarter ended September 30, 2011The Company has posted a net profit of Rs. 1060.50 million for the quarter ended September 30, 2011 as compared to Rs. 729.60 million for the quarter ended September 30, 2010. Total Income has increased from Rs. 2628.10 million for the quarter ended September 30, 2010 to...

pdf

Divi's Laboratories Ltd.

21 Oct 2011

6527.00

-0.34%

Board Meeting

Q2 results on Nov 01, 2011

BSE India

Divis Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 01, 2011 inter-alia, to consider and take on record the un-audited financial results for the second quarter ended September 30, 2011 (Q2).

Divi's Laboratories Ltd.

29 Sep 2011

6527.00

-0.34%

SAST

Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997

BSE India

Divis Laboratories Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:

pdf

Is Divi's Laboratories Ltd. worth buying?

749 Votes:

Buy 78.1%

Sell 14.95%

Hold 6.94%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf

New 52W High in past week

Divi's Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Divi's Laboratories Ltd. on BSE